Alternative Data for McKesson
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 429 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,863,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 87 | Sign up | Sign up | Sign up |
| Facebook Followers | 27,580 | Sign up | Sign up | Sign up |
| Instagram Followers | 11,360 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 8 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,925 | Sign up | Sign up | Sign up |
| X Followers | 21,723 | Sign up | Sign up | Sign up |
| X Mentions | 27 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Lobbying Cost | $407,000 | Sign up | Sign up | Sign up |
| Business Outlook | 66 | Sign up | Sign up | Sign up |
| Linkedin Employees | 24,206 | Sign up | Sign up | Sign up |
About McKesson
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
| Price | $928.69 |
| Target Price | Sign up |
| Volume | 765,801 |
| Market Cap | $113B |
| Year Range | $657.06 - $995.69 |
| Dividend Yield | 0.33% |
| PE Ratio | 26.52 |
| Analyst Rating | 83% buy |
| Industry | Digital health |
In the news
Is McKesson Corporation Stock Outperforming the Nasdaq?March 2 - Yahoo Entertainment |
|
 |
Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in FavorFebruary 25 - Yahoo Entertainment |
 |
Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?February 23 - Yahoo |
|
Faruqi Review Of McKesson Share Plan Puts Dilution And Governance In FocusFebruary 23 - Yahoo |
|
Radiology Information System Market Competitive Landscape Report 2025 Featuring Top Players - Koninklijke Philips, Siemens Healthcare, Oracle, McKesson, GE HealthCareFebruary 23 - Yahoo |
McKesson Corporation: Strong Q3 Earnings But Upside ExhaustedFebruary 23 - SeekingAlpha |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 106B | 102B | 3.69B | 1.19B | 1.84B | 9.340 |
| Q3 '25 | 103B | 99.6B | 3.54B | 1.11B | 1.66B | 9.860 |
| Q2 '25 | 97.8B | 94.5B | 3.28B | 784M | 1.26B | 8.260 |
| Q1 '25 | 90.8B | 87.9B | 2.92B | 1.26B | 1.71B | 10.120 |
| Q4 '24 | 95.3B | 92.1B | 3.22B | 879M | 1.45B | 8.030 |
Insider Transactions View All
| Lau Michele filed to sell 3,247 shares at $990. March 4 '26 |
| Martinez Maria filed to sell 301 shares at $939.9. February 23 '26 |
| Smith LeAnn B filed to sell 2,989 shares at $945. February 18 '26 |
| Lau Michele filed to sell 5,972 shares at $933.4. February 13 '26 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Teladoc HealthTDOC |
$5.57 5.1% | 45 |
 |
Veeva SystemsVEEV |
$189.69 3% | 60 |
 |
DoximityDOCS |
$24.78 2.8% | 72 |
 |
GoodRxGDRX |
$2.4 2.1% | 43 |
 |
Lifestance HealthLFST |
$6.73 2.6% | 55 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Jared Moskowitz |
Jan 19, 26 | Buy | $1K - $15K |
| Gilbert Cisneros |
Jan 13, 26 | Sell | $1K - $15K |
| Jared Moskowitz |
Nov 24, 25 | Buy | $1K - $15K |
Read more about McKesson (MCK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - McKesson
The Market Cap of McKesson is $113B.
As of today, McKesson's PE (Price to Earnings) ratio is 26.52.
Currently, the price of one share of McKesson stock is $928.69.
The MCK stock price chart above provides a comprehensive visual representation of McKesson's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling McKesson shares. Our platform offers an up-to-date MCK stock price chart, along with technical data analysis and alternative data insights.
Yes, McKesson (MCK) offers dividends to its shareholders, with a dividend yield of 0.33%. This dividend yield represents McKesson's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering McKesson in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of McKesson are Teladoc Health, Veeva Systems, Doximity, GoodRx, and Lifestance Health.
